BioPharma Dive Jan 8, 2026 Parabilis, chasing ‘undruggable’ targets, nabs $305M amid VC funding blitz
Illumina Jan 8, 2026 Illumina and PREMIA partner to expand clinical access to CGP in Asia - The Manila Times
Science Jan 8, 2026 IDH-mutant gliomas arise from glial progenitor cells harboring the initial driver mutation | Science
Science Jan 8, 2026 Bark microbiota modulate climate-active gas fluxes in Australian forests | Science
Science Jan 8, 2026 Facial gestures are enacted through a cortical hierarchy of dynamic and stable codes | Science
Agilent Jan 8, 2026 Agilent Technologies, Inc. $A Shares Purchased by Noesis Capital Mangement Corp - MarketBeat
Endpoints News Jan 8, 2026 Ollin’s drug clears retinal disease better than Roche’s Vabysmo in Phase 1b trial